Send feedback

DSP p.Val495Met

c.1483G>A · rs372014020 · VCV228635

Conflicting classifications of pathogenicity Conflicting submitters
Classification
Conflicting classifications of pathogenicity
ClinVar
Review
Conflicting submitters ★☆☆☆
ClinVar · 10 submitters
AlphaMissense
likely pathogenic
0.9536 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 0.00254%, nfe)
Missense predictors
3/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
7
Cardiovascular phenotype

Computational evidence

Protein change
AlphaMissense0.9536likely pathogenic · top 10% in DSP
REVEL0.719pathogenic-leaning
SaProtLLR -10.18damaging
⇒ AlphaMissense, REVEL and SaProt all call this damaging.
Splicing
SpliceAI<0.2no splice effect predicted · four deltas, not one · how we know
Constraint at this position
ConservationphyloP 12GERP 1.9, phastCons 1
Regional constrainto/e 0.94unconstrained · MANE · 29 kb · p 0.14 · regional, not allelic
Overall
CADD30.0PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.00254% European (non-Finnish) · 30/1,180,030 alleles
Filtering AF 0.0018% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.00156%
Overall 0.0109% 176/1,614,082 alleles · very rare exomes 160/1,461,892 · genomes 16/152,190 · joint denominator
Ancestry group Frequency 1 in
Ashkenazi Jewishnot grpmax-eligible 0.409% 245
Remaining individualsnot grpmax-eligible 0.0336% 2,976
European (non-Finnish)grpmax 0.00254% 39,334
East Asian 0.00223% 44,896
South Asian 0.0022% 45,543
Admixed American 0.00167% 60,018

Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
DSP
Protein
p.Val495Met
Coding
c.1483G>A
MANE Select
NM_004415
dbSNP
rs372014020
Type
single nucleotide variant
Location
chr6:7569249 (GRCh38)
Gene constraint
LOEUF 0.443 · pLI 1.00 · ClinGen HI 3/3 (gnomAD)
Residue 495
a β-strand; the 'globular 1' region; the 'interaction with mapre1' region; the 'interaction with jup and pkp2' region; the sh3 domain; a UniProt-annotated variant site (in arvd8; uncertain significance); a UniProt-annotated variant site (in dcwhkta; uncertain significance); a UniProt-annotated variant site (in arvd8; likely pathogenic; results in an unstable protein that forms perinuclear aggregates); a UniProt-annotated variant site (in arvd8 and dcwhkta; uncertain significance); a UniProt-annotated variant site (in arvd8)
Full DSP gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/dsp-p-val495met (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown